This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Recommended imaging schedule for infants younger than 6 months

Authoring team

 

Test

Responds well to treatment within 48 hours

Atypical UTI*

Recurrent UTI*

Ultrasound during the acute infection

No

Yes***

Yes

Ultrasound within 6 weeks

Yes**

No

No

DMSA 4-6 months following the acute infection

No

Yes

Yes

MCUG

No

Yes

Yes

  • *
    • atypical UTI includes:
      • seriously ill
      • poor urine flow
      • abdominal or bladder mass
      • raised creatinine
      • septicaemia
      • failure to respond to treatment with suitable antibiotics within 48 hours
      • infection with non-E. coli organisms

    • recurrent UTI:
      • two or more episodes of UTI with acute pyelonephritis/upper urinary tract infection, or
      • one episode of UTI with acute pyelonephritis/upper urinary tract infection plus one or more episode of UTI with cystitis/lower urinary tract infection, or
      • three or more episodes of UTI with cystitis/lower urinary tract infection
  • **
    • if abnormal consider MCUG
  • ***
    • in an infant or child with a non-E. coli-UTI, responding well to antibiotics and with no other features of atypical infection, the ultrasound can be requested on a non-urgent basis to take place within 6 weeks

Reference:

  1. NICE (September 2017).Urinary tract infection in children: diagnosis, treatment and long-term management

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.